PRESCRIP-TEC: Cervical Cancer Screening in Four Countries

The PRESCRIP-TEC project contributes to the WHO strategy for cervical cancer elimination through implementation research in four countries across three continents. The research focuses on factors affecting the accessibility, acceptability, and quality of an enhanced screening protocol that includes hrHPV testing and AI support. The project aims to answer six specific research questions related to client and health system factors, coverage increases, treatment adherence, and cost-effectiveness.

Use Cases

• Analyze client-related factors for screening accessibility and adherence based on the described research questions.
• Evaluate health system-related factors for service availability and quality based on the project's implementation research.
• Assess the impact of an AI decision support system on reducing observer variation in visual inspection screening.
• Model the cost-effectiveness of a screening protocol combining self-swab hrHPV testing and AI support.

Strengths

• Research is conducted in four distinct countries across three continents, providing a multi-geographic perspective.
• The project addresses six specific, predefined research questions on implementation factors.
• The description references proven interventions like hrHPV testing and AI-supported visual inspection.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for large-scale analysis.

Provenance

Source

DataverseNL Harvested Dataverse

Collection Method

Likely contains data collected from an implementation research project.

Freshness

Last updated 2025-10-15 01:19:10; freshness should be verified.

Geography

Bangladesh, India, Uganda, and Slovakia